Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media

Pediatric Infectious Disease Journal

Volumn 19, Issue 2, 2000, Pages 95-104

  Dagan, Ron ^a   Johnson, Candice E ^b   Mclinn, Samuel ^c   Abughali, Nazha ^d   Feris, Jesus ^f   Leibovitz, Eugene ^a   Burch, Daniel J ^g   Jacobs, Michael R ^e  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Scottsdale Pediatric Center   (United States)

^d METROHEALTH MEDICAL CENTER   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f School of Medicine   (Dominican Republic)

^g GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Acute otitis media; Amoxicillin clavulanate; Azithromycin; Bacteriologic care; Treatment

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CLAVULANIC ACID;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MYRINGOTOMY; OTITIS MEDIA; OTORRHEA; OTOSCOPY; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD, PRESCHOOL; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; OTITIS MEDIA WITH EFFUSION; PENICILLINS; SINGLE-BLIND METHOD; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 0033976135     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200002000-00002     Document Type: Article

References (35)

1. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance: a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999;18:1-9.
2. McCracken GH. Treatment of acute otitis media in an era of increasing microbial resistance. Pediatr Infect Dis J 1998;17: 576-9.
3. Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother 1998;42:589-95.
4. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in non-responsive acute otitis media. Pediatr Infect Dis J 1998;17:1126-31.
5. Marchant CD, Shurin PA, Johnson CE, et al. A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media. J Pediatr 1986; 109:891-6.
6. Johnson CE, Carlin SA, Super DM, et al. Cefixime compared with amoxicillin for treatment of acute otitis media. J Pediatr 1991;119:117-22.
7. Barnett ED, Teele DW, Klein JO, Cabral HJ, Kharasch SJ, and the Greater Boston Otitis Media Study Group. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Pediatrics 1997;99:23-8.
8. Center for Drug Evaluation and Research, US Food and Drug Administration. Draft guidance for industry developing antimicrobial drugs for treatment acute otitis media. 1998. http:// www.fda.gov/cder/present/anti-infective798/aom/index.htm.
9. Marchant PD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: "the Pollyanna phenomenon." J Pediatr 1992; 120:72-7.
10. Dagan R, Fliss DM, Leibovitz E, et al. Antibiotic treatment in acute otitis media: "in vivo" demonstration of antibacterial activity. Clin Microbiol Infect 1997;3(Suppl 3):43-8.
11. Paradise JL. The commentary. Pediatrics 1998;102(Suppl): 221-4.
12. Dagan R, Leibovitz E, Greenberg D, Yagupsky P, Fliss DM, Leiberman A. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J 1998;17:776-82.
13. Carlin SA, Marchant CD, Shurin PA, Johnson CE, Super DM, Rehmus JM. Host factors and early therapeutic response in acute otitis media. J Pediatr 1991;118:178-83.
14. Dagan R, Leibovitz E, Fliss DM, et al. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother (in press).
15. Aronovitz G. A multicenter, open label trial of azithromycin vs. amoxicillin-clavulanate for the management of acute otitis media in children. Pediatr Infect Dis J 1996;15(Suppl): S15-9.
16. Daniel RR. Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children. J Antimicrob Chemother 1993;31(Suppl E):65-71.
17. Khurana CM. A multicenter, randomized, open label comparison of azithromycin and amoxicillin-clavulanate in acute otitis media among children attending day care or school. Pediatr Infect Dis J 1996;15(Suppl):S24-9.
18. McLinn S. A multicenter, double blind comparison of azithromycin and amoxicillin-clavulanate for the treatment of acute otitis media in children. Pediatr Infect Dis J 1996;15(Suppl): S20-3.
19. Principi N. Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin-clavulanic acid in the treatment of paediatric patients with otitis media. Eur J Clin Microbiol Infect Dis 1995;14:669-76.
20. Schaad UB. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children. J Antimicrob Chemother 1993;31(Suppl E):81-8.
21. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996;15: 255-9.
22. Jacobs MR. Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media. Pediatr Infect Dis J 1996;15:940-3.
23. Behre U, Burow HM, Quinn P, Cree F, Harrison HE. Efficacy of twice-daily dosing of amoxycillin-clavulanate in acute otitis media in children. Infection 1997;25:163-6.
24. Reed MD, Blumer JL. Azithromycin: a critical review of the first azilide antibiotic and its role in pediatric practice. Pediatr Infect Dis J 1997;16:1069-83.
25. Klein JO. History of macrolide use in pediatrics. Pediatr Infect Dis J 1997;16:427-31.
26. Murray PR, Barron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: ASM Press, 1995.
27. National Committee for Clinical Laboratory Standards. Methods for dilutional antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Approved standard M7-A4. Wayne, PA: National Committee for Clinical Laboratory Standards, 1995.
28. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996;40:2562-6.
29. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, ninth informational supplement (M 100-S9). Approved standard M7-A3. Wayne, PA: National Committee for Clinical Laboratory Standards, 1999.
30. Dagan R. Bacteriologic response in acute otitis media: comparison between azithromycin, cefaclor, and amoxicillin [Abstract K-103]. In: Thirty-seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, September 28 to October 1, 1997. Washington, DC: American Society for Microbiology, 1997:346.
31. Patel JA, Reisner B, Vizirinia N, et al. Bacteriologic failure of amoxicillin-clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae. J Pediatr 1995;126:799-806.
32. Gladue RP, Bright GM, Isaacson RE, Newborg, MF. In vitro and in vivo uptake of azithromycin (CP-62 993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989;33:277-82.
33. Leibovitz EC, Dragomir S, Sfartz S, et al. Nasopharyngeal (NP) carriage of multi-drug resistant Streptococcus pneumoniae (MDR-PNC) from HIV+ and HIV-children in Northeastern Romania [Abstract K-92]. In: Thirty-seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, September 28 to October 1, 1997. Washington, DC: American Society for Microbiology, 1997:344.
34. Girard AE, Cimochowski CR, Faiella JA. Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection. J Antimicrob Chemother 1996;37(Suppl C):9-19.
35. Scaglione F. Predicting the clinical efficacy of antibiotics: toward definitive criteria. Pediatr Infect Dis J 1997; 16(Suppl):S56-9.